Protective effects of penehyclidine hydrochloride on liver injury in a rat cardiopulmonary bypass model

European Journal of Anaesthesiology

Volumn 27, Issue 9, 2010, Pages 824-828

  Pei, Ling ^a   Cai, Da Sheng ^a   Jin, Bei Bei ^b   Jin, Zhen ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Cardiopulmonary bypass; Liver injury; Penehyclidine hydrochloride

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHLORAL HYDRATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LIVER ENZYME; PENEHYCLIDINE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATTENUATION; BLOOD PRESSURE; BLOOD SAMPLING; BREATHING RATE; CARDIOPULMONARY BYPASS; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ELECTROCARDIOGRAM; ELECTRON MICROSCOPE; FEMORAL ARTERY; HEART RATE; HISTOPATHOLOGY; LIVER; LIVER FUNCTION; LIVER INJURY; LIVER PROTECTION; LOW DRUG DOSE; MALE; NONHUMAN; RAT; SHAM PROCEDURE; SURGICAL TECHNIQUE; TISSUE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

ALANINE TRANSAMINASE; ANESTHESIOLOGY; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARDIOPULMONARY BYPASS; FEMORAL ARTERY; HEART RATE; INFLAMMATION; LIVER; MALE; MICROSCOPY, ELECTRON; POSTOPERATIVE PERIOD; QUINUCLIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77956864143     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32833b650f     Document Type: Article

References (32)

1. Ascione R, Talpahewa S, Rajakaruna C, et al. Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg 2006; 81:97-103.
2. Hyde JA, Riddington DW, Hutton P, et al. Prevention of remote organ injury in cardiopulmonary bypass: the impact of flow generation technique. Artif Organs 1997; 21:825-829.
3. Zhang S, Wang S, Li Q, et al. Capillary leak syndrome in children with C4A-deficiency undergoing cardiac surgery with cardiopulmonary bypass: a double-blind, randomised controlled study. Lancet 2005; 366:556-562.
4. Link J, Schafer M, Gramm HJ. Cardiopulmonary bypass in brain-dead organ donors. The Brain Death Study Group. Lancet 1993; 341:238-239.
5. Edmunds LH. Cardiopulmonary bypass after 50 years. N Engl J Med 2004; 351:1603-1606.
6. Potzsch B, Klovekorn WP, Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med 2000; 343:515.
7. Ohki S, Oshima K, Takeyoshi I, et al. Endotoxin removal with a polymyxin B- immobilized hemoperfusion cartridge improves cardiopulmonary function after cardiopulmonary bypass. J Surg Res 2008; 145:74-79.
8. Miyaji K, Miyamoto T, Kohira S, et al. Miniaturized cardiopulmonary bypass system in neonates and small infants. Interact Cardiovasc Thorac Surg 2008; 7:75-78.
9. Lauten A, Liebing K, Franke U, Wahlers T. The Jena universal perfusion system: a universal cardiopulmonary bypass circuit for cardiac surgery. Interact Cardiovasc Thorac Surg 2007; 6:1-4.
10. Elahi MM, Khan JS, Matata BM. Deleterious effects of cardiopulmonary bypass in coronary artery surgery and scientific interpretation of off-pump's logic. Acute Card Care 2006; 8:196-209.
11. Thoren A, Nygren A, Houltz E, Ricksten SE. Cardiopulmonary bypass in humans: jejunal mucosal perfusion increases in parallel with well maintained microvascular hematocrit. Acta Anaesthesiol Scand 2005; 49:502-509.
12. Mollhoff T, Loick HM, Van Aken H, et al. Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). Anesthesiology 1999; 90:72-80.
13. Ohri SK, Bowles CT, Siddiqui A, et al. The effect of cardiopulmonary bypass on gastric and colonic mucosal perfusion: a tonometric assessment. Perfusion 1994; 9:101-108.
14. Shoji T, Omasa M, Nakamura T, et al. Mild hypothermia ameliorates lung ischemia reperfusion injury in an ex vivo rat lung model. Eur Surg Res 2005; 37:348-353.
15. Liang SW, Chen YM. Effects of penehyclidine hydrochloride or atropine combined with neostigmine for antagonizing residual neuromuscular block on patient's hemodynamics. Di Yi Jun Yi Da Xue Xue Bao 2005; 25:1581-1582.
16. Han XY, Liu H, Liu CH, et al. Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). Bioorg Med Chem Lett 2005; 15:1979-1982.
17. Yin L, Li K, Lu L. Clinical observation of penehyclidine hydrochloride as the preanesthetic medication before operation for patients with cleft lip/palate. Hua Xi Kou Qiang Yi Xue Za Zhi 2008; 26:413-415.
18. Gong P, Zhang Y, Liu H, et al. Effects of penehyclidine hydrochloride on the splanchnic perfusion of patients with septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2008; 20:183-186.
19. Zhan J, Wang Y, Wang C, et al. Protective effects of penehyclidine hydrochloride on septic mice and its mechanism. Shock 2007; 28:727-732. (Pubitemid 350135480)
20. Sun Yj, Chen WM, Cao HJ, et al. Effects of penehyclidine on the intestinal mucous membrane barrier function in rats undergoing cardiopulmonary bypass. Chin J Anesthesiol 2007; 27:1099.
21. Gourlay T, Ballaux PK, Draper ER, Taylor KM. Early experience with a new technique and technology designed for the study of pulsatile cardiopulmonary bypass in the rat. Perfusion 2002; 17:191-198.
22. Ito K, Ozasa H, Yoneya R, Horikawa S. Splenectomy ameliorates hepatic ischemia and reperfusion injury mediated by heme oxygenase-1 induction in the rat. Liver 2002; 22:467-473. (Pubitemid 36004284)
23. Shen Z, Wang Z, Zhang J, Jing H. Hepatic injury in a rat cardiopulmonary bypass model. Interact Cardiovasc Thorac Surg 2008; 7:18-22.
24. Huang H, Yin R, Zhu J, et al. Exogenous melatonin ameliorates hepatic injury in a rat cardiopulmonary bypass model. Eur J Pharmacol 2008; 580:416-424.
25. Viaro F, Baldo CF, Capellini VK, et al. Plasma nitrate/nitrite (NOx) is not a useful biomarkerto predict inherent cardiopulmonary bypass inflammatory response. J Card Surg 2008; 23:336-338.
26. Sobieski MA 2nd, Graham JD, Pappas PS, et al. Reducing the effects of the systemic inflammatory response to cardiopulmonary bypass: can single dose steroids blunt systemic inflammatory response syndrome? ASAIO J 2008; 54:203-206.
27. Rahman A, Aydin S, Bayar MK, Sahin I. Changes of ghrelin and brain natriuretic peptide levels in systemic vascular resistance after cardiopulmonary bypass. J Physiol Biochem 2008; 64:221-230.
28. Lucas MT, Limoli J, Schlut J, Holt DW. Does zero balance ultrafiltration decrease the incidence of postcardiopulmonary bypass atrial fibrillation? J Extra Corpor Technol 2008; 40:109-115.
29. Kerbaul F, Benard F, Giorgi R, et al. Adenosine A2A receptor hyperexpression in patients with severe SIRS after cardiopulmonary bypass. J Investig Med 2008; 56:864-871.
30. Isbir CS, Ergen A, Tekeli A, et al. The effect of NQO1 polymorphism on the inflammatory response in cardiopulmonary bypass. Cell Biochem Funct 2008; 26:534-538.
31. Lei LR, Wang YL, Jia BH. Protective effect of penehyclidine hydrochloride on lung injury in mice with sepsis and its mechanism. Zhongguo WeiZhong Bing Ji Jiu Yi Xue 2007; 19:623-624.
32. Kodaka M, Okamoto Y, Kakoi H. The effects of premedication on induction doses of propofol and hemodynamic responses during induction. Masui 1997; 46:1347-1353. (Pubitemid 27488360)